Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
Tóm tắt
Từ khóa
Tài liệu tham khảo
Rosenberg, 1965, Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode, Nature, 205, 698, 10.1038/205698a0
Wang, 2005, Cellular processing of platinum anticancer drugs, Nat Rev Drug Discov, 4, 307, 10.1038/nrd1691
Cohen, 2001, Cisplatin: from DNA damage to cancer chemotherapy, Prog Nucleic Acid Res Mol Biol, 67, 93, 10.1016/S0079-6603(01)67026-0
Siddik, 2003, Cisplatin: mode of cytotoxic action and molecular basis of resistance, Oncogene, 22, 7265, 10.1038/sj.onc.1206933
Ciccarelli, 1985, In vivo effects of cis- and trans-diamminedichloroplatinum(II) on SV40 chromosomes: differential repair, DNA-protein cross-linking, and inhibition of replication, Biochemistry, 24, 7533, 10.1021/bi00347a005
Heiger-Bernays, 1990, Effect of the antitumor drug cis-diamminedichloroplatinum(II) and related platinum complexes on eukaryotic DNA replication, Biochemistry, 29, 8461, 10.1021/bi00488a037
Zamble, 1995, Cisplatin and DNA repair in cancer chemotherapy, Trends Biochem Sci, 20, 435, 10.1016/S0968-0004(00)89095-7
Jamieson, 1999, Structure, recognition, and processing of cisplatin-DNA adducts, Chem Rev, 99, 2467, 10.1021/cr980421n
Eastman, 1987, The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes, Pharmacol Ther, 34, 155, 10.1016/0163-7258(87)90009-X
Kartalou, 2001, Mechanisms of resistance to cisplatin, Mutat Res, 478, 23, 10.1016/S0027-5107(01)00141-5
Wernyj, 2004, Molecular mechanisms of platinum resistance: still searching for the Achilles' heel, Drug Resist Updat, 7, 227, 10.1016/j.drup.2004.08.002
Siddik, 2002, Biochemical and molecular mechanisms of cisplatin resistance, Cancer Treat Res, 112, 263, 10.1007/978-1-4615-1173-1_13
Pasetto, 2006, The development of platinum compounds and their possible combination, Crit Rev Oncol Hematol, 60, 59, 10.1016/j.critrevonc.2006.02.003
Cornelison, 1993, Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin, Gynecol Oncol, 50, 147, 10.1006/gyno.1993.1184
Bajorin, 1986, Pharmacokinetics of cis-diamminedichloroplatinum(II) after administration in hypertonic saline, Cancer Res, 46, 5969
Hill, 1982, Organo-platinum complexes as antitumor agents (review), Anticancer Res, 2, 173
Beyer, 1997, Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome, Bone Marrow Transplant, 20, 813, 10.1038/sj.bmt.1700980
Gonzales-Vitale, 1977, The renal pathology in clinical trials of cis-platinum (II) diamminedichloride, Cancer, 39, 1362, 10.1002/1097-0142(197704)39:4<1362::AID-CNCR2820390403>3.0.CO;2-N
Gomez Campdera, 1986, Cisplatin nephrotoxicity: symptomatic hypomagnesemia and renal failure, Int J Pediatr Nephrol, 7, 151
Gately, 1993, Cellular accumulation of the anticancer agent cisplatin: a review, Br J Cancer, 67, 1171, 10.1038/bjc.1993.221
Ishida, 2002, Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals, Proc Natl Acad Sci USA, 99, 14298, 10.1073/pnas.162491399
Kuo, 2007, The roles of copper transporters in cisplatin resistance, Cancer Metastasis Rev, 26, 71, 10.1007/s10555-007-9045-3
Safaei, 2005, Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs, Crit Rev Oncol Hematol, 53, 13, 10.1016/j.critrevonc.2004.09.007
Kuo, 2006, Copper transport protein (Ctr1) levels in mice are tissue specific and dependent on copper status, J Nutr, 136, 21, 10.1093/jn/136.1.21
Ludwig, 2004, Nephrotoxicity of platinum complexes is related to basolateral organic cation transport, Kidney Int, 66, 196, 10.1111/j.1523-1755.2004.00720.x
Yonezawa, 2005, Association between tubular toxicity of cisplatin and expression of organic cation transporter rOCT2 (Slc22a2) in the rat, Biochem Pharmacol, 70, 1823, 10.1016/j.bcp.2005.09.020
Motohashi, 2002, Gene expression levels and immunolocalization of organic ion transporters in the human kidney, J Am Soc Nephrol, 13, 866, 10.1681/ASN.V134866
Ciarimboli, 2005, Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2, Am J Pathol, 167, 1477, 10.1016/S0002-9440(10)61234-5
Townsend, 2003, Metabolism of cisplatin to a nephrotoxin in proximal tubule cells, J Am Soc Nephrol, 14, 1, 10.1097/01.ASN.0000042803.28024.92
Hanigan, 1994, Inhibition of gamma-glutamyl transpeptidase activity by acivicin in vivo protects the kidney from cisplatin-induced toxicity, Cancer Res, 54, 5925
Hanigan, 2001, Gamma-glutamyl transpeptidase-deficient mice are resistant to the nephrotoxic effects of cisplatin, Am J Pathol, 159, 1889, 10.1016/S0002-9440(10)63035-0
Hanigan, 1999, Gamma-glutamyl transpeptidase accelerates tumor growth and increases the resistance of tumors to cisplatin in vivo, Carcinogenesis, 20, 553, 10.1093/carcin/20.4.553
Lieberthal, 1996, Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis, Am J Physiol, 270, F700
Megyesi, 1998, Induction of p21WAF1/CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure, J Clin Invest, 101, 777, 10.1172/JCI1497
Ramesh, 2003, TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure, Am J Physiol Renal Physiol, 285, F610, 10.1152/ajprenal.00101.2003
Liu, 2003, Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis, Kidney Int, 63, 1687, 10.1046/j.1523-1755.2003.00908.x
Faubel, 2004, Caspase-1-deficient mice are protected against cisplatin-induced apoptosis and acute tubular necrosis, Kidney Int, 66, 2202, 10.1111/j.1523-1755.2004.66010.x
Ramesh, 2005, p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice, Am J Physiol Renal Physiol, 289, F166, 10.1152/ajprenal.00401.2004
Li, 2004, PPAR-alpha ligand ameliorates acute renal failure by reducing cisplatin-induced increased expression of renal endonuclease G, Am J Physiol Renal Physiol, 287, F990, 10.1152/ajprenal.00206.2004
Wei, 2007, The pathological role of Bax in cisplatin nephrotoxicity, Kidney Int, 72, 53, 10.1038/sj.ki.5002256
Tsuruya, 2003, Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death, Kidney Int, 63, 72, 10.1046/j.1523-1755.2003.00709.x
Dursun, 2006, Caspases and calpain are independent mediators of cisplatin-induced endothelial cell necrosis, Am J Physiol Renal Physiol, 291, F578, 10.1152/ajprenal.00455.2005
Razzaque, 1999, Cisplatin-induced apoptosis in human proximal tubular epithelial cells is associated with the activation of the Fas/Fas ligand system, Histochem Cell Biol, 111, 359, 10.1007/s004180050368
Ramesh, 2002, TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity, J Clin Invest, 110, 835, 10.1172/JCI200215606
Ramesh, 2004, Inflammatory cytokines in acute renal failure, Kidney Int Suppl, 66, S56, 10.1111/j.1523-1755.2004.09109.x
Lee, 2001, Cisplatin-induced apoptosis by translocation of endogenous Bax in mouse collecting duct cells, Biochem Pharmacol, 62, 1013
Park, 2002, Cisplatin induces apoptosis in LLC-PK1 cells via activation of mitochondrial pathways, J Am Soc Nephrol, 13, 858, 10.1681/ASN.V134858
Jiang, 2004, Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity, Am J Physiol Renal Physiol, 287, F1140, 10.1152/ajprenal.00262.2004
Jiang, 2006, Regulation of PUMA-alpha by p53 in cisplatin-induced renal cell apoptosis, Oncogene, 25, 4056, 10.1038/sj.onc.1209440
Jiang, 2007, Nutlin-3 protects kidney cells during cisplatin therapy by suppressing Bax/Bak activation, J Biol Chem, 282, 2636, 10.1074/jbc.M606928200
Nagothu, 2005, Fibrate prevents cisplatin-induced proximal tubule cell death, Kidney Int, 68, 2680, 10.1111/j.1523-1755.2005.00739.x
Seth, 2005, p53-dependent caspase-2 activation in mitochondrial release of apoptosis-inducing factor and its role in renal tubular epithelial cell injury, J Biol Chem, 280, 31230, 10.1074/jbc.M503305200
Wangila, 2006, Prevention of cisplatin-induced kidney epithelial cell apoptosis with a Cu superoxide dismutase-mimetic [copper2II(3,5-ditertiarybutylsalicylate)4(ethanol)4], Toxicol In vitro, 20, 1300, 10.1016/j.tiv.2006.04.002
Jiang, 2007, Effects of hydroxyl radical scavenging on cisplatin-induced p53 activation, tubular cell apoptosis and nephrotoxicity, Biochem Pharmacol, 73, 1499, 10.1016/j.bcp.2007.01.010
Wang, 2004, Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria, J Biol Chem, 279, 19948, 10.1074/jbc.M313629200
Yang, 2007, Mcl-1 is downregulated in cisplatin-induced apoptosis, and proteasome inhibitors restore Mcl-1 and promote survival in renal tubular epithelial cells, Am J Physiol Renal Physiol, 292, F1710, 10.1152/ajprenal.00505.2006
Sheikh-Hamad, 2004, Cellular and molecular studies on cisplatin-induced apoptotic cell death in rat kidney, Arch Toxicol, 78, 147, 10.1007/s00204-003-0521-4
Brooks, 2007, Bak regulates mitochondrial morphology and pathology during apoptosis by interacting with mitofusins, Proc Natl Acad Sci USA, 104, 11649, 10.1073/pnas.0703976104
Boyce, 2006, Cellular response to endoplasmic reticulum stress: a matter of life or death, Cell Death Differ, 13, 363, 10.1038/sj.cdd.4401817
Liu, 2005, Endoplasmic reticulum stress-associated caspase 12 mediates cisplatin-induced LLC-PK1 cell apoptosis, J Am Soc Nephrol, 16, 1985, 10.1681/ASN.2004090768
Peyrou, 2007, Cisplatin, gentamicin, and p-aminophenol induce markers of endoplasmic reticulum stress in the rat kidneys, Toxicol Sci, 99, 346, 10.1093/toxsci/kfm152
Cummings, 2004, Role of an endoplasmic reticulum Ca2+-independent phospholipase A2 in cisplatin-induced renal cell apoptosis, J Pharmacol Exp Ther, 308, 921, 10.1124/jpet.103.060541
Cummings, 2002, Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways, J Pharmacol Exp Ther, 302, 8, 10.1124/jpet.302.1.8
Vandenabeele, 2006, Caspase inhibitors promote alternative cell death pathways, Sci STKE, 2006, pe44, 10.1126/stke.3582006pe44
Price, 2003, Cell cycle regulation: repair and regeneration in acute renal failure, Semin Nephrol, 23, 449, 10.1016/S0270-9295(03)00087-1
Delaval, 2007, A cell cycle hypothesis of cooperative oncogenesis (Review), Int J Oncol, 30, 1051
Bloom, 2007, Multiple levels of cyclin specificity in cell-cycle control, Nat Rev Mol Cell Biol, 8, 149, 10.1038/nrm2105
Ishikawa, 2006, DNA damage-dependent cell cycle checkpoints and genomic stability, DNA Cell Biol, 25, 406, 10.1089/dna.2006.25.406
Megyesi, 1996, The p53-independent activation of transcription of p21 WAF1/CIP1/SDI1 after acute renal failure, Am J Physiol Renal Physiol, 271, F1211, 10.1152/ajprenal.1996.271.6.F1211
Price, 2004, Protection of renal cells from cisplatin toxicity by cell cycle inhibitors, Am J Physiol Renal Physiol, 286, F378, 10.1152/ajprenal.00192.2003
Yu, 2005, Identification of the functional domain of p21(WAF1/CIP1) that protects cells from cisplatin cytotoxicity, Am J Physiol Renal Physiol, 289, F514, 10.1152/ajprenal.00101.2005
Price, 2006, Dependence of cisplatin-induced cell death in vitro and in vivo on cyclin-dependent kinase 2, J Am Soc Nephrol, 17, 2434, 10.1681/ASN.2006020162
Yu, 2007, The involvement of the Cdk2-E2f1 pathway in cisplatin cytotoxicity in vitro and in vivo, Am J Physiol Renal Physiol, 293, F52, 10.1152/ajprenal.00119.2007
Wei, 2007, Activation and involvement of p53 in cisplatin-induced nephrotoxicity, Am J Physiol Renal Physiol, 293, F1282, 10.1152/ajprenal.00230.2007
Chipuk, 2004, Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis, Science, 303, 1010, 10.1126/science.1092734
Zhou, 2004, The induction of cell cycle regulatory and DNA repair proteins in cisplatin-induced acute renal failure, Toxicol Appl Pharmacol, 200, 111, 10.1016/j.taap.2004.04.003
Wang, 2006, Caspase-mediated cleavage of ATM during cisplatin-induced tubular cell apoptosis: inactivation of its kinase activity toward p53, Am J Physiol Renal Physiol, 291, F1300, 10.1152/ajprenal.00509.2005
Pabla N, Huang S, Mi QS et al. ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis. J Biol Chem;e-pub ahead of print 27 December 2007.
Itoh, 1999, A novel chaperone-activity-reducing mechanism of the 90-kDa molecular chaperone HSP90, Biochem J, 343, 697, 10.1042/bj3430697
Satoh, 1994, Induction and altered localization of 90-kDa heat-shock protein in rat kidneys with cisplatin-induced acute renal failure, Ren Fail, 16, 313, 10.3109/08860229409044872
Owens, 2007, Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases, Oncogene, 26, 3203, 10.1038/sj.onc.1210412
Zhuang, 2006, A death-promoting role for extracellular signal-regulated kinase, J Pharmacol Exp Ther, 319, 991, 10.1124/jpet.106.107367
Nowak, 2002, Protein kinase C-alpha and ERK1/2 mediate mitochondrial dysfunction, decreases in active Na+ transport, and cisplatin-induced apoptosis in renal cells, J Biol Chem, 277, 43377, 10.1074/jbc.M206373200
Arany, 2004, Cisplatin-induced cell death is EGFR/src/ERK signaling dependent in mouse proximal tubule cells, Am J Physiol Renal Physiol, 287, F543, 10.1152/ajprenal.00112.2004
Kim, 2005, Role of ERK activation in cisplatin-induced apoptosis in OK renal epithelial cells, J Appl Toxicol, 25, 374, 10.1002/jat.1081
Jo, 2005, MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis, Kidney Int, 67, 458, 10.1111/j.1523-1755.2005.67102.x
Mishima, 2006, Protective effect of cyclic AMP against cisplatin-induced nephrotoxicity, Free Radic Biol Med, 40, 1564, 10.1016/j.freeradbiomed.2005.12.025
Francescato, 2007, Effect of JNK inhibition on cisplatin-induced renal damage, Nephrol Dial Transplant, 22, 2138, 10.1093/ndt/gfm144
Baliga, 1999, Oxidant mechanisms in toxic acute renal failure, Drug Metab Rev, 31, 971, 10.1081/DMR-100101947
Kruidering, 1997, Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain, J Pharmacol Exp Ther, 280, 638
Davis, 2001, Manganese superoxide dismutase attenuates Cisplatin-induced renal injury: importance of superoxide, J Am Soc Nephrol, 12, 2683, 10.1681/ASN.V12122683
Ma, 2007, Combining cisplatin with cationized catalase decreases nephrotoxicity while improving antitumor activity, Kidney Int, 72, 1474, 10.1038/sj.ki.5002556
Baliga, 1998, Role of cytochrome P-450 as a source of catalytic iron in cisplatin-induced nephrotoxicity, Kidney Int, 54, 1562, 10.1046/j.1523-1755.1998.00161.x
Baliga, 1998, In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity, Kidney Int, 53, 394, 10.1046/j.1523-1755.1998.00767.x
Agarwal, 1995, Induction of heme oxygenase in toxic renal injury: a protective role in cisplatin nephrotoxicity in the rat, Kidney Int, 48, 1298, 10.1038/ki.1995.414
Shiraishi, 2000, Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis, Am J Physiol Renal Physiol, 278, F726, 10.1152/ajprenal.2000.278.5.F726
Schaaf, 2002, Management of oxidative stress by heme oxygenase-1 in cisplatin-induced toxicity in renal tubular cells, Free Radic Res, 36, 835, 10.1080/1071576021000005267
Agarwal, 2000, Renal response to tissue injury: lessons from heme oxygenase-1 GeneAblation and expression, J Am Soc Nephrol, 11, 965, 10.1681/ASN.V115965
Tayem, 2006, Protection against cisplatin-induced nephrotoxicity by a carbon monoxide-releasing molecule, Am J Physiol Renal Physiol, 290, F789, 10.1152/ajprenal.00363.2005
Dickey, 2005, Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels, J Pharmacol Exp Ther, 314, 1052, 10.1124/jpet.105.087601
Matsushima, 1998, The role of oxygen free radicals in cisplatin-induced acute renal failure in rats, J Lab Clin Med, 131, 518, 10.1016/S0022-2143(98)90060-9
Tsuruya, 2003, Antioxidant ameliorates cisplatin-induced renal tubular cell death through inhibition of death receptor-mediated pathways, Am J Physiol Renal Physiol, 285, F208, 10.1152/ajprenal.00311.2002
Sener, 2000, The protective effect of melatonin on cisplatin nephrotoxicity, Fundam Clin Pharmacol, 14, 553, 10.1111/j.1472-8206.2000.tb00440.x
Baldew, 1989, Selenium-induced protection against cis-diamminedichloroplatinum(II) nephrotoxicity in mice and rats, Cancer Res, 49, 3020
Naziroglu, 2004, Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats, Toxicology, 195, 221, 10.1016/j.tox.2003.10.012
Weijl, 2004, Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study, Eur J Cancer, 40, 1713, 10.1016/j.ejca.2004.02.029
Pace, 2003, Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy, J Clin Oncol, 21, 927, 10.1200/JCO.2003.05.139
Atessahin, 2005, Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats, Toxicology, 212, 116, 10.1016/j.tox.2005.04.016
De Martinis, 2001, Effect of vitamin C supplementation against cisplatin-induced toxicity and oxidative DNA damage in rats, Pharmacol Res, 44, 317, 10.1006/phrs.2001.0860
Appenroth, 1997, Protective effects of vitamin E and C on cisplatin nephrotoxicity in developing rats, Arch Toxicol, 71, 677, 10.1007/s002040050444
Shimeda, 2005, Protective effects of capsaicin against cisplatin-induced nephrotoxicity in rats, Biol Pharm Bull, 28, 1635, 10.1248/bpb.28.1635
Al-Majed, 2003, Effect of oral administration of Arabic gum on cisplatin-induced nephrotoxicity in rats, J Biochem Mol Toxicol, 17, 146, 10.1002/jbt.10072
Bonventre, 2003, Recent advances in the pathophysiology of ischemic acute renal failure, J Am Soc Nephrol, 14, 2199, 10.1097/01.ASN.0000079785.13922.F6
Devarajan, 2006, Update on mechanisms of ischemic acute kidney injury, J Am Soc Nephrol, 17, 1503, 10.1681/ASN.2006010017
Lu, 2007, The inflammatory response to ischemic acute kidney injury: a result of the ‘right stuff’ in the ‘wrong place’?, Curr Opin Nephrol Hypertens, 16, 83, 10.1097/MNH.0b013e3280403c4e
Deng, 2001, Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury, Kidney Int, 60, 2118, 10.1046/j.1523-1755.2001.00043.x
Ramesh, 2004, Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-alpha, Kidney Int, 65, 490, 10.1111/j.1523-1755.2004.00413.x
Ramesh, 2006, Cisplatin increases TNF-alpha mRNA stability in kidney proximal tubule cells, Ren Fail, 28, 583, 10.1080/08860220600843839
Ramesh, 2007, Endotoxin and cisplatin synergistically induce renal dysfunction and cytokine production in mice, Am J Physiol Renal Physiol, 293, F325, 10.1152/ajprenal.00158.2007
Zhang, 2007, Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells, Kidney Int, 72, 37, 10.1038/sj.ki.5002242
Dong, 2007, Tumor necrosis factor-alpha in cisplatin nephrotoxicity: a homebred foe?, Kidney Int, 72, 5, 10.1038/sj.ki.5002320
Ramesh, 2007, Endotoxin and cisplatin synergistically stimulate TNF-alpha production by renal epithelial cells, Am J Physiol Renal Physiol, 292, F812, 10.1152/ajprenal.00277.2006
Liu, 2006, A pathophysiologic role for T lymphocytes in murine acute cisplatin nephrotoxicity, J Am Soc Nephrol, 17, 765, 10.1681/ASN.2005010102
Faubel, 2007, Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infiltration in the kidney, J Pharmacol Exp Ther, 322, 8, 10.1124/jpet.107.119792
Klein, 1991, Renal handling of cisplatin: interactions with organic anions and cations in the dog, Clin Invest Med, 14, 388
Townsend, 2002, Inhibition of gamma-glutamyl transpeptidase or cysteine S-conjugate beta-lyase activity blocks the nephrotoxicity of cisplatin in mice, J Pharmacol Exp Ther, 300, 142, 10.1124/jpet.300.1.142
Hanigan, 1996, Cisplatin nephrotoxicity: inhibition of gamma-glutamyl transpeptidase blocks the nephrotoxicity of cisplatin without reducing platinum concentrations in the kidney, Am J Obstet Gynecol, 175, 270, 10.1016/S0002-9378(96)70134-5
Sadzuka, 1994, Protection against cisplatin-induced nephrotoxicity in the rat by inducers and an inhibitor of glutathione S-transferase, Biochem Pharmacol, 48, 453, 10.1016/0006-2952(94)90274-7
Nisar, 2002, N-acetylcysteine as salvage therapy in cisplatin nephrotoxicity, Ren Fail, 24, 529, 10.1081/JDI-120006780
Sheikh-Hamad, 1997, Cisplatin-induced renal toxicity: possible reversal by N-acetylcysteine treatment, J Am Soc Nephrol, 8, 1640, 10.1681/ASN.V8101640
Zunino, 1989, Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drug, Chem Biol Interact, 70, 89, 10.1016/0009-2797(89)90065-3
Santos, 2007, Hydroxyl radical scavenger ameliorates cisplatin-induced nephrotoxicity by preventing oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria, Cancer Chemother Pharmacol, 61, 145, 10.1007/s00280-007-0459-y
Kim, 2005, Xanthorrhizol has a potential to attenuate the high dose cisplatin-induced nephrotoxicity in mice, Food Chem Toxicol, 43, 117, 10.1016/j.fct.2004.08.018
Mora Lde, 2003, The effects of oral glutamine on cisplatin-induced nephrotoxicity in rats, Pharmacol Res, 47, 517, 10.1016/S1043-6618(03)00040-9
Atasoyu, 2005, Investigation of the role of hyperbaric oxygen therapy in cisplatin-induced nephrotoxicity in rats, Arch Toxicol, 79, 289, 10.1007/s00204-004-0627-3
Behling, 2006, Comparative study of multiple dosage of quercetin against cisplatin-induced nephrotoxicity and oxidative stress in rat kidneys, Pharmacol Rep, 58, 526
Saad, 2000, The effect of rebamipide on cisplatin-induced nephrotoxicity in rats, Pharmacol Res, 42, 81, 10.1006/phrs.2000.0662
Li, 1994, Effect of arginine on cisplatin-induced acute renal failure in the rat, Biochem Pharmacol, 47, 2298, 10.1016/0006-2952(94)90269-0
Saleh, 2005, Protective effects of L-arginine against cisplatin-induced renal oxidative stress and toxicity: role of nitric oxide, Basic Clin Pharmacol Toxicol, 97, 91, 10.1111/j.1742-7843.2005.pto_114.x
Li, 2005, Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF, Am J Physiol Renal Physiol, 289, F469, 10.1152/ajprenal.00038.2005
Lee, 2006, Rosiglitazone ameliorates cisplatin-induced renal injury in mice, Nephrol Dial Transplant, 21, 2096, 10.1093/ndt/gfl194
Girnun, 2007, Synergy between PPARgamma ligands and platinum-based drugs in cancer, Cancer Cell, 11, 395, 10.1016/j.ccr.2007.02.025
Capizzi, 1999, Amifostine reduces the incidence of cumulative nephrotoxicity from cisplatin: laboratory and clinical aspects, Semin Oncol, 26, 72
Fenoglio, 2002, Protective effect of procaine hydrochloride on cisplatin-induced alterations in rat kidney, Anticancer Drugs, 13, 1043, 10.1097/00001813-200211000-00008